Search

Penumbra Inc

Geschlossen

BrancheGesundheitswesen

324.02 0.56

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

321.02

Max

323.64

Schlüsselkennzahlen

By Trading Economics

Einkommen

163M

33M

Verkäufe

-11M

375M

KGV

Branchendurchschnitt

73.446

64.641

EPS

1.01

Gewinnspanne

8.695

Angestellte

4,700

EBITDA

-22M

47M

Empfehlungen

By TipRanks

Empfehlungen

Neutral

12-Monats-Prognose

+11.59% upside

Dividenden

By Acuity

Nächstes Ergebnis

4. Aug. 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-203M

13B

Vorheriger Eröffnungskurs

323.46

Vorheriger Schlusskurs

324.02

Nachrichtenstimmung

By Acuity

100%

0%

320 / 340 Ranking in Healthcare

Penumbra Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

3. Aug. 2026, 21:01 UTC

Penumbra Inc. shares are lower in after-market trading, despite gains in the broader market. The decline began shortly after Monday's close.

24. Juli 2026, 16:36 UTC

Correlated Moves

Penumbra Inc's shares are higher today, supported by gains in the medical devices sector and a decline in oil prices easing inflation concerns.

Peer-Vergleich

Kursveränderung

Penumbra Inc Prognose

Kursziel

By TipRanks

11.59% Vorteil

12-Monats-Prognose

Durchschnitt 358.4 USD  11.59%

Hoch 374 USD

Tief 320 USD

Basierend auf 6 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Penumbra Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Neutral

6 ratings

1

Buy

5

Halten

0

Sell

Stimmung

By Acuity

320 / 340 Ranking in Gesundheitswesen

Nachrichtenstimmung

Sehr starke bärische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Penumbra Inc

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX Select, BENCHMARK, BMX96, BMX81, DDC, SENDit, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization Device, aspiration tubing, and aspiration pump under the Penumbra RED, JET, ACE, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that includes the Penumbra Coil 400, a detachable coil that provides an alternative for the treatment of aneurysms and other complex lesions, as well as Penumbra SMART COIL, a detachable coil to treat patients with a wide range of neurovascular lesions; and POD400 and PAC400 brands. In addition, the company provides peripheral embolization products, such as Ruby Coil System consisting of detachable coils for peripheral applications; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers an immersive 3D computer-based technology platform under the real immersive system brand; and neurosurgical tools, such as Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.
help-icon Live chat